California Neuro Disease Research Update: A Search for Unique Opportunities and Bottlenecks to Break

$1.5 billion must be spent by voter mandate

CIRM’s neuro disease clinical portfolio as of last fall. Additional funds were spent in earlier stage research.

California’s stem cell and gene therapy agency will delve tomorrow into its $1.5 billion mandate to finance research involving neuro diseases ranging from autism to stroke as the agency seeks to hire a new president, a process that will take mo…